First Round of Abstract Submission Ends:
Before September 26, 2025
Early Bird Registration:
September 29, 2025
Home
About
About ICETCR 2026
Dates
Experts
Abstract
Abstract Submission
Review Process
Speaker Guidelines
Poster Guidelines
E-Poster Guidelines
Presentation Guidelines
Sponsor
Exhibition (Tabletop) Opportunities
Sponsor Opportunities
Become A Sponsor
Venue
Register
ICETCR-2026
Home
About
About ICETCR 2026
Dates
Experts
Abstract
Abstract Submission
Review Process
Speaker Guidelines
Poster Guidelines
E-Poster Guidelines
Presentation Guidelines
Sponsor
Exhibition (Tabletop) Opportunities
Sponsor Opportunities
Become A Sponsor
Venue
Register Now
Abstract Submission
Home
Abstract Submission
Abstract Submission
Title
Dr.
Mr.
Mrs.
Ms.
Name
Email
Organization
Telephone
City
Country
Select country
Select country
United States
United Kingdom
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Canadian Nunavut Territory
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling Islands)
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Cote D'Ivoire (Ivory Coast)
Croatia (Hrvatska)
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
France, Metropolitan
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Heard and McDonald Islands
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea (North)
Korea (South)
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Qatar
Reunion
Romania
Russian Federation
Rwanda
S. Georgia and S. Sandwich Isls.
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovak Republic
Slovenia
Solomon Islands
Somalia
South Africa
Spain
Sri Lanka
St. Helena
St. Pierre and Miquelon
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
US Minor Outlying Islands
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Vatican City State (Holy See)
Venezuela
Viet Nam
Virgin Islands (British)
Wallis and Futuna Islands
Western Sahara
Yemen
Yugoslavia
Zaire
Zambia
Zimbabwe
Interested In
Poster Presentation
Oral Presentation
Conducting Workshop
Conducting Symposium
Others
Sessions
Select
CAR-T and CAR-NK cell therapies
Bispecific and multispecific antibodies
Cancer vaccines and neoantigen targeting
Immune checkpoint modulation beyond PD-1/PD-L1
Epigenetic therapies
Synthetic lethality and DNA damage response
Cancer stem cells and tumor heterogeneity
Overcoming drug resistance
AI-driven diagnostic imaging and pathology
Machine learning for predictive modeling
Digital health and wearable tech
Natural language processing for clinical data
Tumor dissemination mechanisms
Circulating tumor cells
EMT and therapies to prevent metastases
Circulating tumor DNA (ctDNA)
Exosome and biomarker discovery
Non-invasive screening programs
Immune/stromal cell crosstalk
Hypoxia and angiogenesis
Metabolic vulnerabilities
Targeting fibroblasts and macrophages
Whole genome and single-cell sequencing
Liquid biopsies for tumor monitoring
Molecular tumor boards and clinical decision support
Targeting rare mutations and resistance mechanisms
Innovative trial designs
Biomarker-driven precision trials
Patient recruitment and diversity
Accelerated regulatory pathways
Cancer burden in low- and middle-income countries
Access and equity challenges
Capacity building and culturally sensitive care
Cancer Genomics & Epigenomics
Pediatric and Rare Cancers
Cancer Stem Cells and Tumor Heterogeneity
Neuro-Oncology and Brain Tumors
Metabolomics and Systems Biology
Cancer Epitranscriptomics
Attach File
Sample Abstract File
Download Template
225
13
39
50
Register
April 8-10, 2026
Novotel Phuket Resort, Phuket, Thailand
April 8-10, 2026
Novotel Phuket Resort, Phuket, Thailand
+65 9189 1271
associate@asiacancermeet.com
yuktan.com